KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Depreciation & Amortization (CF) (2016 - 2025)

Cme (CME) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $26.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 6.38% to $26.4 million in Q3 2025 year-over-year; TTM through Dec 2025 was $81.0 million, a 6.9% decrease, with the full-year FY2025 number at $107.5 million, down 6.6% from a year prior.
  • Depreciation & Amortization (CF) was $26.4 million for Q3 2025 at Cme, down from $27.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $37.6 million in Q1 2021 to a low of $26.4 million in Q3 2025.
  • A 5-year average of $31.7 million and a median of $31.9 million in 2023 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): increased 6.52% in 2021, then decreased 11.15% in 2024.
  • Cme's Depreciation & Amortization (CF) stood at $37.2 million in 2021, then dropped by 7.26% to $34.5 million in 2022, then decreased by 9.86% to $31.1 million in 2023, then decreased by 9.32% to $28.2 million in 2024, then decreased by 6.38% to $26.4 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Depreciation & Amortization (CF) are $26.4 million (Q3 2025), $27.3 million (Q2 2025), and $27.3 million (Q1 2025).